ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

CHRISTOPHER CHOI MD

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,011Medicare Part D Prescriptions Filled, Including Refills

Rank: 63 out of 393

$413K Total Retail Price of All Prescriptions

Rank: 97 out of 393

219 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 219 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

17% of this provider’s 219 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 7,132 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
WARFARIN SODIUM 442 332 1 17
MORPHINE SULFATE ER 346 255 S2 2 48
FUROSEMIDE 322 292 3 8
LISINOPRIL 212 190 4 2
HYDROCODONE-ACETAMINOPHEN 209 137 S3 5 5
POTASSIUM CHLORIDE 199 173 6 20
METOPROLOL TARTRATE 193 153 7 9
SIMVASTATIN 188 144 8 1
LEVOTHYROXINE SODIUM 179 161 9 3
MIRTAZAPINE 138 138 10 89
RISPERIDONE 136 99 11 75
OXYCODONE HCL 134 95 S2 12 36
TAMSULOSIN HCL 127 105 13 25
AMLODIPINE BESYLATE 125 106 14 4
LIDODERM 123 93 15 116
CYMBALTA 123 98 15 88
RANITIDINE HCL 122 114 17 29
GABAPENTIN 120 83 18 15
OMEPRAZOLE 118 92 19 6
PANTOPRAZOLE SODIUM 117 59 20 56
EXELON 117 117 20 151
DONEPEZIL HCL 114 95 22 34
NAMENDA 110 103 23 59
CITALOPRAM HBR 108 89 24 23
ALBUTEROL SULFATE 93 86 25 92
ZOLPIDEM TARTRATE 89 68 26 11
MORPHINE SULFATE 88 75 S2 27 190
LEVEMIR FLEXPEN 75 75 28 117
LEVETIRACETAM 67 34 29 112
FAMOTIDINE 67 58 29 70
IPRATROPIUM BROMIDE 66 51 31 106
LOSARTAN POTASSIUM 65 51 32 12
SERTRALINE HCL 65 63 32 28
HYDRALAZINE HCL 64 64 34 64
FLUTICASONE PROPIONATE 64 51 34 27
QUETIAPINE FUMARATE 57 45 36 104
METFORMIN HCL 56 51 37 7
CLOPIDOGREL 54 38 38 33
NOVOLOG FLEXPEN 53 52 39 127
TRAMADOL HCL 52 30 40 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 3, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.